AUGMENTED LONGEVITY

Welcome to the Brand page for “AUGMENTED LONGEVITY”, which is offered here for Cells and biological preparations intended for medical and clinical use, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, auto-immune diseases, inflammatory diseases, crohn's disease and multiple myeloma; biological products for medical use, placental-derived natural killer cells, and placental-derived cytotoxic t cells with a chimeric antigen receptor (car) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, placental-derived cytotoxic t cells with a chimeric antigen receptor (car) specific for a cancer or other disease associated antigen;.

Its status is currently believed to be active. Its class is unavailable. “AUGMENTED LONGEVITY” is believed to be currently owned by “CELULARITY INC.”

Owner:
CELULARITY INC.
Owner Details
Description:
Cells and biological preparations intended for medical and clinical use, blood, stem cells, umbilical cords, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological preparations for medical use for the treatment of cancer and other diseases, auto-immune diseases, inflammatory diseases, Crohn's Disease and Multiple Myeloma; biological products for medical use, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen; cells and biological tissue intended for hair restoration, cells and biological preparations derived from blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease associated antigen;
Categories: CELLS BIOLOGICAL PREPARATIONS INTENDED